Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
AVDL
AVDL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AVDL News
Alkermes Acquires Avadel to Expand Product Portfolio
3d ago
Newsfilter
State Street Increases Stake in Avadel Pharmaceuticals by 2.39%
Jan 19 2026
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.36%
Jan 16 2026
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals, Holding Reaches 2.36%
Jan 15 2026
Globenewswire
Avadel Pharmaceuticals Shareholders Approve Alkermes Buyout
Jan 12 2026
Yahoo Finance
State Street Increases Stake in Avadel Pharmaceuticals by 2.36%
Jan 09 2026
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.35%
Jan 08 2026
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.36%
Jan 07 2026
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.35%
Jan 06 2026
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.34%
Jan 02 2026
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.35%
Dec 31 2025
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.35%
Dec 30 2025
Globenewswire
State Street Increases Stake in Avadel Pharmaceuticals by 2.35%
Dec 24 2025
Globenewswire
Market Update: Health Care Stocks Show Varied Performance Ahead of Thursday's Opening Bell
Dec 18 2025
Yahoo Finance
Avadel Completes Patient Enrollment in REVITALYZ Trial, Data Expected Q2 2026
Dec 18 2025
Newsfilter
Weiss Asset Management Discloses 2.17% Stake in Avadel Pharmaceuticals
Dec 17 2025
Businesswire
Show More News
